Following the European Court of Justice ruling, that plants obtained by recent techniques such as CRISPR-Cas9-mediated genome editing mutagenesis are regulated as GMO, the VIB statement addresses the huge problems Europe will face in plant breeding in the future. EPSO anticipates the same problems as depicted in the statement, which is in line with our first reaction, and will publish a full statement in November.

European Research Infrastructures (ESFRI) Roadmap 2018 published, identifying 8 projects with ESFRI Landmark status and 6 new projects entering the roadmap.

The State of Food Security and Nutrition in the World (SOFI) 2018 setting out actions to achieve the goal by 2030 and confirming a rise in world hunger: the number of people who suffer from hunger has been growing over the past three years, returning to levels from almost a decade ago. Multiple forms of malnutrition are evident in many countries: adult obesity is growing even as forms of undernutrition persist. Climate variability and extremes are key drivers behind this rise, together with conflict and economic downturns.

High level event: Sustainable and circular Bioeconomy Conference on 22.10.2018 in Brussels. Online registration opened. See more information.

EPSO publishes a first reaction to the Court of Justice of the EU ruling regarding mutagenesis and the GMO Directive in which European Plant Scientists express their disappointment on the ruling which classifies plants obtained by recent techniques such as CRISPR-Cas9-mediated genome editing as GMO that are subject to extensive pre-market risk evaluations. It is contrary to scientific evidence and as it stands now, it very likely will prevent the use in Europe of such technologies to address food and nutritional security and a more positive impact of agriculture on the environment. EPSO offers to collaborate with policy makers to develop an appropriate regulation addressing the issue of how a product of NBTs differs from those achieved with other breeding approaches to balance potential benefits and risks. See brief statements from EPSO members and partners on the ECJ ruling regarding mutagenesis and GMO Directive.